The Rs 30.24 crore IPO, which comprised entirely a fresh issue of 14.54 lakh shares, witnessed overwhelming investor interest during the three-day bidding period. The issue was subscribed 385.32 times, driven by robust participation across all investor categories.
The Rs 30.24 crore Avience Biomedicals IPO, comprising 14.54 lakh shares, garnered overwhelming investor interest. The issue was subscribed an astounding 385.32 times, driven by robust participation across all investor categories. This strong demand ahead of its listing signals…
Market Samachar is a news aggregator. This article was originally published by Markets-Economic Times. Tap the button above to read the full story on their site.